Table 2.
Results of MRD, FISH, and qRT-PCR analyses for the patients.
| Time point | Laboratory findings | Patient 1 | Patient 2 | Patient 3 |
|---|---|---|---|---|
| TP1 | MRD | <10−4 | 0.38% | 1.38% |
| FISH | Negative | Negative | Negative | |
| IS BCR-ABL1 | 0.012 | 0.015 | 0.0015 | |
| TP2 | MRD | <10−4 | <10−4 | <10−4 |
| FISH | Negative | Negative | Negative | |
| IS BCR-ABL1 | Negative | Negative | Negative | |
| Every 6 months after chemotherapy | FISH | Negative | Negative | Negative |
| IS BCR-ABL1 | Negative | Negative | Negative | |
| ABL1 mutation | Negative | Negative | Negative |
TP: time point; MRD: minimal residual disease; FISH: fluorescence in situ hybridization.